VEXAS syndrome is a rare inflammatory condition that usually starts in adulthood, often in older men. Early symptoms of VEXAS syndrome can include fevers, extreme tiredness, skin rashes, joint or cartilage pain, shortness of breath, and low blood counts. VEXAS syndrome is usually long lasting and can worsen over time, though not everyone will have the same experience. It can be serious and sometimes life threatening, especially when inflammation affects the lungs, blood, or bone marrow. Treatment for VEXAS syndrome often includes steroids and other medicines that calm the immune system, and some people may also need care for related blood disorders.
How many people live with Vexas syndrome?
Worldwide, there is no single direct count for VEXAS syndrome, but using the best available rates by age and sex suggests roughly 200,000 to 250,000 people may be living with it around the world (Geisinger MyCode Community Health Initiative, 2023; United Nations World Population Prospects, 2022). In the United States, the same data suggest about 15,000 to 20,000 people may be living with VEXAS syndrome, although this is an estimate rather than a direct national count (Geisinger MyCode Community Health Initiative, 2023).
Overview
Vexas syndromeSymptoms
VEXAS syndrome often causes recurrent fevers, extreme tiredness, shortness of breath, and painful skin rashes. Many living with VEXAS syndrome also have aching joints, swollen cartilage in the ears or nose, and anemia that can make everyday activity feel draining.
Outlook and prognosis
VEXAS syndrome is usually a long-term, relapsing inflammatory illness, and outlook depends on which organs are affected and how well treatment controls flares. Many people need ongoing care, and serious blood or lung problems can make prognosis less favorable.
Causes and risk factors
VEXAS syndrome is caused by an acquired change in the UBA1 gene, meaning it develops during life and is not usually inherited. It mainly affects older adults, especially men. No clear lifestyle or environmental risk factors are known.
Genetic influences
Genetics are central to VEXAS syndrome. It is usually caused by a change in the UBA1 gene that arises later in life rather than being inherited, so other genetic variations are not usually the main driver.
Diagnosis
VEXAS syndrome is diagnosed by reviewing symptoms and exam findings, along with blood tests that often show inflammation and abnormal blood counts. Doctors usually confirm the diagnosis with genetic testing for a change in the UBA1 gene.
Treatment and drugs
Treatment for VEXAS syndrome often combines steroids for flares with other immune-calming medicines to reduce steroid use over time. Some people need blood transfusions or treatment for blood clots. In severe cases, stem cell transplant may be considered.
Symptoms
VEXAS syndrome often shows up as repeated inflammatory flares that can leave people feeling unwell for long stretches, not just during a short illness. The changes are often subtle at first, blending into daily life until they become more noticeable. The early symptoms of VEXAS syndrome can look like ongoing flu-like episodes, skin problems, pain, and unusual tiredness. Because VEXAS syndrome can affect the blood, lungs, skin, and joints, symptoms may come and go but often become harder to ignore over time.
Fevers are common and may keep coming back without a clear infection. Some people have chills, sweats, and a heavy washed-out feeling during these flares.
Tiredness can be severe and out of proportion to activity. Day to day, it can feel like simple tasks such as shopping, climbing stairs, or cooking take much more effort than usual.
Painful or tender red or purple patches can appear on the skin, often on the arms or legs. The skin may look inflamed, and the rash can come back during flare-ups.
Aching, stiffness, and swelling in the joints are common, especially in the hands, knees, ankles, or wrists. Many living with VEXAS syndrome find that moving after rest is harder and everyday activities become less comfortable.
How people usually first notice Vexas syndrome?
Many people first notice VEXAS syndrome when what seems like one problem does not stay just one problem: repeated fevers, a painful rash, ear or nose inflammation, shortness of breath, or unusual fatigue keep coming back, often along with blood test abnormalities such as anemia, which means a low red blood cell count. For many living with VEXAS syndrome, the first warning signs show up in adulthood, often later in life, and may look at first like an autoimmune or inflammatory illness that does not respond as expected to standard treatment. How VEXAS syndrome is first noticed can vary, but doctors often begin to suspect it when severe inflammation and unexplained low blood counts appear together rather than as separate issues.
Types of Vexas syndrome
VEXAS syndrome can affect day-to-day life in several ways, from ongoing fevers and exhaustion to painful skin changes or shortness of breath that make simple tasks harder. It is an adult-onset inflammatory condition, and doctors usually describe it by the main symptom patterns it causes rather than by fixed disease subtypes. It can be helpful to think of symptoms in categories. Early symptoms of VEXAS syndrome may look different from what shows up later, and not everyone will have the same mix.
Inflammatory symptoms
Many people with VEXAS syndrome have repeated fevers, marked fatigue, and a strong feeling of being unwell. These flares can come and go or become more constant over time. Joint pain, muscle aches, and weight loss are also common.
Blood changes
VEXAS syndrome often affects the blood and bone marrow, which can lead to anemia and low blood counts. For many, this can mean unusual tiredness, weakness, easy bruising, or more frequent infections. Some people are first noticed to have abnormal blood tests before the full picture becomes clear.
Skin problems
Skin symptoms are common in VEXAS syndrome and may include tender rashes, red or purple patches, or swelling that can be painful to touch. One person might struggle mostly with recurring spots on the arms or legs, while another notices more widespread redness and soreness. These changes often flare along with other inflammatory symptoms.
Lung symptoms
Some people with VEXAS syndrome develop breathing problems such as shortness of breath, cough, or chest discomfort. Others are more noticeable during walking, climbing stairs, or when a flare is active. In some cases, inflammation in the lungs becomes a major part of the illness.
Cartilage and vessels
VEXAS syndrome can also cause inflammation in cartilage and blood vessels, leading to painful ears or nose, headaches, or symptoms linked to reduced blood flow. Symptoms don’t always look the same for everyone. Some may also develop blood clots, which need prompt medical attention.
Can I slow down the onset of symptoms?
At this time, there is no good evidence that lifestyle changes or preventive treatment can meaningfully delay the start of symptoms in VEXAS syndrome. This condition is linked to a change that develops in blood-forming cells later in life, so things like diet, exercise, sleep, or supplements have not been shown to prevent it, although staying generally healthy can still support your overall health and may make it easier to cope with illness if symptoms appear. There are no well-established screening or prevention guidelines for people without symptoms, but early medical care can help control inflammation once it begins, and research into better treatments is ongoing.
What genetics can tell you about symptoms
In VEXAS syndrome, genetics can tell doctors a lot because the condition is caused by acquired changes in the UBA1 gene that develop later in life, rather than being inherited from a parent. These gene changes are linked to the pattern of inflammation people may have, including fevers, skin rashes, lung inflammation, low blood counts, and painful swelling in the cartilage, and some genetic differences may be tied to how severe the illness is or which problems stand out most. Even so, symptoms can still vary from one person to another, so the genetic result is only one piece of the picture.
Causes and risk factors
When unexplained fevers, rashes, and fatigue keep coming back, VEXAS syndrome is usually due to an acquired change in the UBA1 gene. This change appears after birth in blood-forming cells, so it is not usually inherited from a parent. The main risk factors for VEXAS syndrome are older age and being assigned male at birth because the gene is on the X chromosome. Researchers are still learning how these pieces fit together. No clear lifestyle or environmental cause has been proven, and smoking, diet, or everyday exposures are not known to cause VEXAS syndrome.
What are the most common causes or risk factors?
VEXAS syndrome is mainly caused by a gene change that develops later in life in blood-forming cells, in a gene called UBA1, so it is usually not passed down from a parent. It is most often seen in older adults, especially men or people assigned male at birth, and there are no well-proven lifestyle or environmental risk factors at this time.
Environmental and biological risk factors
VEXAS syndrome is rare, and doctors are still learning why it appears in some people and not others. When people ask who is at risk for VEXAS syndrome, the clearest patterns are biological, while proven environmental triggers remain unclear. Doctors often group risks into internal (biological) and external (environmental).
This condition is usually diagnosed later in adulthood, often after age 50. One reason may be that age-related changes can build up over time in blood-forming stem cells.
It affects mostly people assigned male at birth. It is much less common in women, though it can occur, especially when one X chromosome is missing in some cells.
Many living with VEXAS syndrome also have an abnormal expansion of one group of blood cells or a related bone marrow disorder. This suggests shared problems in the blood-forming system that may raise the chance of the syndrome appearing.
No specific exposure in the environment has been firmly proven to raise risk. At this time, factors such as pollution, infections, or chemical contact are still being studied, but none are established causes.
Genetic risk factors
VEXAS syndrome usually starts with a gene change that appears later in life in blood-forming cells, rather than a change inherited from a parent. The key gene is called UBA1, and because it sits on the X chromosome, the condition is seen far more often in people assigned male at birth. Family history is usually absent, although rare women with loss of one X chromosome can also develop VEXAS syndrome.
UBA1 change: VEXAS syndrome is caused by a harmful change in the UBA1 gene. This gene helps blood-forming cells manage certain protein-building steps, and when it is altered, widespread inflammation can develop.
Acquired mutation: In most people, the UBA1 change is not present from birth and is not passed down through a family. It develops later in blood-forming stem cells, which is why the genetic causes of VEXAS syndrome are different from many inherited disorders.
X chromosome: The UBA1 gene sits on the X chromosome. Changes in genes on the X chromosome can have a stronger effect when there is no healthy backup copy available in the same cell.
Male sex: VEXAS syndrome is found mainly in people assigned male at birth. That is because they usually have one X chromosome, so a damaging UBA1 change is more likely to cause disease.
Rare female cases: Women can rarely develop VEXAS syndrome, usually when there is also loss of one X chromosome in some or all cells. This can happen in conditions such as Turner syndrome or with age-related loss of the X chromosome in blood cells.
Lifestyle risk factors
Lifestyle habits do not cause VEXAS syndrome, but they can influence inflammation, symptom burden, treatment tolerance, and the risk of complications. Because this condition often affects the lungs, blood vessels, skin, joints, and blood counts, daily habits matter most when they change stress on these systems. Understanding how lifestyle affects VEXAS syndrome can help people reduce avoidable strain while medical treatment targets the underlying disease.
Smoking can worsen lung inflammation, increase infection risk, and add to the breathing problems that many people with VEXAS syndrome already face. It may also raise the risk of blood vessel complications and make steroid-related heart and circulation risks more concerning.
Heavy alcohol use can aggravate anemia, strain the liver, and complicate the monitoring of inflammation and medication side effects in VEXAS syndrome. It can also worsen fatigue and interact poorly with drugs used to control flares.
Too little activity can worsen deconditioning, muscle weakness, and clot risk during periods of illness or steroid treatment. Gentle, tailored exercise may help preserve strength, stamina, and joint function without pushing through active inflammatory flares.
Excess body weight can add mechanical stress to painful joints and may worsen breathlessness, sleep disruption, and cardiometabolic strain in people with VEXAS syndrome. Severe undernutrition or unintended weight loss can also reduce resilience during flares and infections.
Risk prevention
VEXAS syndrome usually cannot be prevented, because it is linked to a gene change that develops later in life rather than something you are born with or can reliably avoid. For many living with VEXAS syndrome, prevention is mainly about lowering the risk of flares, infections, blood clots, lung problems, and damage from long-term inflammation. Prevention works best when combined with regular check-ups.
Regular care with specialists can help catch inflammation, anemia, lung trouble, or skin and cartilage problems before they become more serious. This often includes blood tests and monitoring symptoms over time so treatment can be adjusted early.
Taking medicines exactly as prescribed can help prevent VEXAS syndrome flares and reduce harm from ongoing inflammation. Because steroids and other immune treatments can raise infection risk, people with VEXAS syndrome also need close monitoring for side effects.
Good hand hygiene, staying up to date with vaccines recommended by your care team, and avoiding close contact with people who are clearly ill can lower the chance of infection. This matters because many living with VEXAS syndrome take treatments that weaken the immune system.
VEXAS syndrome can raise the risk of blood clots, so staying active, keeping well hydrated, and following advice about blood thinners when prescribed may help lower that risk. Quick care for new leg swelling, chest pain, or sudden shortness of breath can prevent dangerous complications.
Can you prevent Vexas syndrome?
No, there is no known way to prevent VEXAS syndrome. It is usually caused by a genetic change that develops later in life in blood-forming cells, not by anything you did or did not do, and there are no proven lifestyle steps that can stop it from happening.
Transmission
VEXAS syndrome is not contagious, so you cannot catch it from someone through the air, close contact, sex, food, or blood. For many living with VEXAS syndrome, the key point is that it usually starts from a gene change that appears later in life in some blood-forming cells rather than being something passed between people.
That is why, when people ask how VEXAS syndrome is inherited, the answer is that it is usually not inherited from a parent and is not commonly passed on to children. In rare situations, a genetics specialist may look more closely at family history and testing, but the usual genetic transmission of VEXAS syndrome is considered acquired after birth, not family-based.
When to test your genes
Consider genetic testing for VEXAS if an older adult, especially a man, develops unexplained fevers, inflamed cartilage, rashes, lung inflammation, blood clots, or low blood counts that do not fit a usual diagnosis or respond poorly to treatment. Testing the UBA1 gene can confirm the condition and help guide care.
Diagnosis
VEXAS syndrome is usually suspected when an adult has ongoing inflammation that does not fit a more common diagnosis, often along with low blood counts, fevers, skin rashes, or breathing problems. It’s natural to worry when symptoms don’t have a clear explanation. The diagnosis of VEXAS syndrome often takes time because its early signs can look like several different blood, immune, or rheumatology conditions.
Doctors start by looking closely at the pattern of symptoms, including repeated fevers, fatigue, painful skin changes, joint pain, shortness of breath, or swelling. They also ask when symptoms began and whether they keep coming back or are getting worse over time.
The exam looks for signs of inflammation, such as rash, tender cartilage of the ears or nose, swollen joints, or leg swelling. Findings on the exam help guide which blood, lung, or bone marrow tests are most useful next.
Blood tests often show inflammation and may also find anemia or other low blood counts. These results do not prove VEXAS syndrome on their own, but they can raise suspicion and help rule out infections, autoimmune diseases, and blood cancers.
Many people with VEXAS syndrome need a bone marrow test if blood counts are low or unexplained. Doctors look for characteristic changes in developing blood cells and for related bone marrow disorders that can occur alongside VEXAS syndrome.
How is Vexas syndrome diagnosed?
Doctors usually suspect VEXAS syndrome in adults who have repeated episodes of body-wide inflammation together with low blood counts, and blood tests often show high inflammation and red blood cells that are larger than usual. They may also check a bone marrow sample, because the blood-making cells can show a pattern that fits this condition. The diagnosis is confirmed by finding a change in the UBA1 gene, usually with a genetic test done on blood or bone marrow.
Stages of Vexas syndrome
Vexas syndrome does not have defined progression stages. This is because it does not usually follow a clear step-by-step pattern over time; instead, symptoms can flare, improve, or build up differently from one person to another. Often the process begins when you notice changes in daily life, such as repeated fevers, painful rashes, shortness of breath, or worsening fatigue, and doctors then look at the overall pattern, including early symptoms of Vexas syndrome. Diagnosis is usually based on symptoms, blood tests, examination findings, and often genetic testing to confirm the change linked to the condition, while follow-up focuses on tracking inflammation, blood counts, and organ involvement over time.
Outlook and prognosis
The outlook for people with VEXAS syndrome is variable but often serious, with many patients having a chronic, relapsing inflammatory illness that can progressively damage quality of life and major organs. Prognosis depends heavily on which complications develop, especially severe anemia or other bone marrow failure, recurrent lung inflammation, blood clots, vasculitis, and associated hematologic disorders such as myelodysplastic syndrome. Many patients need long-term corticosteroids, but steroid dependence and treatment-resistant disease are common, and these can worsen overall outcomes. Published cohorts suggest a substantial risk of premature death, with mortality often related to progressive inflammatory complications, infection, thrombosis, or evolution of an underlying blood disorder. Early recognition and care by specialists in rheumatology and hematology can improve symptom control and may reduce complications, particularly as targeted therapies and stem cell transplantation are considered in selected patients. Because VEXAS syndrome was only recently recognized, long-term survival estimates are still evolving, but close follow-up is important given the potentially life-threatening course.
Long-term effects
VEXAS syndrome can have lasting effects because ongoing inflammation may involve several parts of the body at once, and many people need long-term medical follow-up. For some, day-to-day life may be shaped by fatigue, repeated flares, and the need for treatment over months or years. The long-term picture is often very different from one person to another, depending on which organs are affected and how well inflammation responds to treatment.
VEXAS syndrome often causes ongoing abnormalities in the blood, including anemia, which can leave people feeling weak, short of breath, or unusually tired. Some also develop low white blood cells or platelets, which can raise the risk of infections, bruising, or bleeding.
Many living with VEXAS syndrome have repeated episodes of fever, body aches, and high levels of inflammation in the blood. Over time, these flares can become a major part of the illness and may continue even when treatment helps for a while.
Inflammation can affect the lungs and cause long-term breathing problems, cough, or reduced exercise tolerance. In more severe cases, lung involvement can become a major part of prognosis and may require oxygen or hospital care.
Some people with VEXAS syndrome have recurring rashes, tender skin changes, or inflammation in the ears and nose known as chondritis. These problems may come and go, but in some people they become persistent and add to pain or visible changes over time.
How is it to live with Vexas syndrome?
Living with VEXAS syndrome can feel unpredictable, because flares of inflammation may bring intense fatigue, fevers, shortness of breath, joint or cartilage pain, and skin problems that can interrupt work, sleep, and everyday plans. Many people living with VEXAS also need frequent medical visits, blood tests, and treatments, and some may find that symptoms come and go while others deal with more persistent limits on stamina and physical activity. This can affect the people around you too, as family members and caregivers often help with appointments, monitor for serious symptoms, and adjust routines during flares, but good medical follow-up and practical support can make daily life more manageable.
Treatment and drugs
VEXAS syndrome is usually treated by calming the body’s overactive inflammation and managing blood problems at the same time, since many living with VEXAS syndrome have both. Steroid medicines such as prednisone often help quickly with fever, rash, joint pain, or breathing symptoms, but high doses may be needed and long-term use can cause side effects. Not every treatment works the same way for every person, so doctors may also use other immune-calming drugs, targeted medicines, and supportive care such as blood transfusions, especially when anemia or other low blood counts are part of the illness. For some people with severe VEXAS syndrome, a stem cell transplant may be considered because it is currently the only treatment that may offer a lasting cure, although it carries serious risks and is not right for everyone.
Can you cure Vexas syndrome?
There is no simple or widely suitable cure for VEXAS syndrome. For most people, treatment focuses on calming inflammation, easing symptoms, and treating related blood problems, often with steroid medicines and other drugs that help control an overactive immune system. In some people, a donor stem cell transplant may offer a chance of cure, but it has serious risks and is not the right choice for everyone.
Non-drug treatment
Day-to-day care for VEXAS syndrome often goes beyond medicines, especially when fatigue, shortness of breath, joint pain, or anemia make ordinary tasks harder. Managing this condition often means combining rehabilitation, supportive care, and careful monitoring to help protect function and quality of life. For many, treatment begins not at the pharmacy, but with practical steps like energy pacing, nutrition support, and help staying active safely. Because symptoms can vary a lot, non-drug treatment for VEXAS syndrome is usually tailored to the problems affecting you most.
Gentle strength and mobility work can help many living with VEXAS syndrome stay steadier and reduce stiffness. This is often most useful when fatigue or joint pain has made walking, climbing stairs, or getting up from a chair more difficult.
Occupational therapists help people with VEXAS syndrome make daily tasks easier and less draining. They may suggest pacing, hand supports, or home adjustments so cooking, bathing, and dressing take less effort.
If VEXAS syndrome affects the lungs, breathing exercises and supervised conditioning can improve stamina and help with breathlessness. Some may also benefit from oxygen support or airway clearance techniques when inflammation has reduced lung function.
Activity needs to be balanced with rest, because pushing too hard can worsen exhaustion and recovery time. Simple routines—like short walks or seated exercises—can have lasting benefits when they are adjusted to your energy level.
Your genes may have an impact on how drugs work for you
In VEXAS syndrome, the illness itself is caused by a genetic change that happens in some blood-making cells, and that can help explain why medicines used to calm inflammation may work very differently from one person to another. Many living with VEXAS improve for a while on steroid medicines, for example when fevers, rash, or painful swelling settle down, but some may find the benefit fades, high doses are needed, or side effects become a big problem. Right now, doctors do not usually use separate drug-response genetic testing to choose treatment for VEXAS, but the disease-causing genetic change can still help confirm the condition and guide care overall.
Pharmacological treatments
Treatment for VEXAS syndrome often starts with medicines that calm inflammation and ease day-to-day symptoms such as fever, painful skin rashes, shortness of breath, and joint pain. Doctors usually tailor treatment to how active the disease is and whether there is also a bone marrow problem such as myelodysplastic syndrome, so the best treatment for VEXAS syndrome can look different from one person to another. Not everyone responds to the same medication in the same way.
Prednisone and other corticosteroids are often the first medicines used because they can work quickly to bring inflammation under control. Many living with VEXAS syndrome improve at first, but symptoms often return when the dose is lowered, so long-term high doses can become a problem.
Tocilizumab is one of the better-known targeted drugs used for VEXAS syndrome, especially when steroids alone are not enough. It may help reduce inflammation and steroid needs in some people, though the benefit can vary.
Ruxolitinib is used in many centers for VEXAS syndrome and may help with fevers, skin symptoms, blood inflammation markers, and steroid dependence. Other drugs in this group, such as baricitinib, have also been used in some cases.
Anakinra, canakinumab, and tumor necrosis factor blockers such as infliximab or adalimumab have been tried in some people with VEXAS syndrome. These medicines may help certain inflammatory symptoms, but results have generally been less consistent than with steroids, tocilizumab, or ruxolitinib.
Genetic influences
When fevers, painful skin changes, or deep fatigue keep returning, many people with VEXAS syndrome want to know why. VEXAS syndrome is caused by a change in the UBA1 gene, but unlike many inherited conditions, this change usually develops later in life in blood-forming cells instead of being passed down from a parent. DNA testing can sometimes identify these changes. Because only some cells carry the change, doctors think of VEXAS syndrome as an acquired genetic condition, and relatives usually are not at higher risk just because one family member has it. VEXAS syndrome is seen mostly in men because the affected gene is on the X chromosome, although it can rarely affect women in certain situations. Understanding this genetic cause helps doctors confirm the diagnosis and choose treatments that address both the inflammation and the blood-related problems.
Is Vexas syndrome genetic?
Genetics are central to VEXAS syndrome. It is usually caused by a change in the UBA1 gene that arises later in life rather than being inherited, so other genetic variations are not usually the main driver.
Having a genetic risk is not necessarily a diagnosis
Genetic variants are a usual part of human biology and are common throughout the general population. Most do not have a direct effect on health and are simply part of normal human diversity. For many genes, having a variant associated with a condition suggests a possible link rather than a certain diagnosis, especially when several genes and environmental factors are involved. In some cases, though, one well-understood variant in a particular gene can be enough to confirm a diagnosis.
Pharmacogenetics—how genetics influence drug effects
For many living with VEXAS syndrome, the hardest part is that fevers, pain, skin changes, or shortness of breath may improve with steroids and then flare again when the dose is lowered. This happens because VEXAS syndrome is driven by an acquired change in the UBA1 gene in blood-forming cells, so the inflammation is coming from the bone marrow itself rather than from a short-term trigger. Doctors can use your genetic information to help guide treatment, including whether to try medicines that reduce immune overactivity, whether steroid-sparing drugs are likely to be needed, and when to discuss a stem cell transplant in severe cases. The same genetic finding can also prompt doctors to look closely for related blood disorders, which can affect which drugs are safest and most useful. Not every difference in response is genetic, but in VEXAS syndrome the UBA1 mutation is central to both diagnosis and treatment planning. If you are wondering about genetic testing for VEXAS syndrome treatment, it is often a key step because it helps explain why standard treatments may not work well enough on their own.
Interactions with other conditions
People living with VEXAS syndrome often deal with more than one health problem at once, and the pattern can be complicated. It commonly overlaps with blood disorders, especially myelodysplastic syndrome, and some may also develop other bone marrow conditions or abnormal blood proteins, so VEXAS syndrome and blood disorders are an important part of care. Doctors call it a “comorbidity” when two conditions occur together. Many with VEXAS syndrome also have strong inflammation that affects the lungs, skin, joints, or blood vessels, and this can look similar to illnesses such as relapsing polychondritis or vasculitis. Another key concern is a higher risk of blood clots, which can add to breathing problems, leg swelling, or chest pain and needs prompt medical attention. Because these overlaps can change both symptoms and treatment choices, people with VEXAS syndrome often do best when hematology, rheumatology, and primary care teams work closely together.
How genes can cause diseases
Humans have more than 20,000 genes, each carrying out one or a few specific functions in the body. One gene instructs the body to digest lactose from milk, another tells the body how to build strong bones and another prevents the body's cells from beginning to multiply uncontrollably and developing into cancer. As all of these genes combined are the building instructions for our body, a defect in one of these genes can have severe health consequences.
Through decades of genetic research, we know the genetic code of any healthy/functional human gene. We have also identified that in certain positions on a gene, some individuals may have a different genetic letter from the one you have. We call these hotspots "Genetic Variations" or "Variants" in short. In many cases, studies have been able to show that having the genetic letter "G" in the position makes you healthy, but having the letter "A" in the same position disrupts the gene function and causes a disease. Genopedia allows you to view these variants in genes and summarizes all that we know from scientific research, which genetic letters (Genotype) have good or bad consequences on your health or on your traits.
What other conditions can cause similar symptoms to Vexas syndrome?
VEXAS syndrome can look a lot like other inflammatory illnesses, especially relapsing polychondritis, which can cause painful swelling of the ears and nose, vasculitis, which is inflammation of the blood vessels, and adult-onset Still disease. It can also be mistaken for immune conditions such as lupus or rheumatoid arthritis, and for bone marrow problems such as myelodysplastic syndrome or some blood cancers, because these can also cause fevers, rash, joint pain, anemia, and very abnormal blood tests. Because the overlap is so strong, doctors often need blood work, and sometimes bone marrow and genetic testing, to tell them apart.
History
For many living with VEXAS syndrome, the hardest part at first was not having a name for what was happening. Someone might spend months or years dealing with repeated fevers, painful inflammation, unusual blood test results, skin rashes, or breathing trouble, moving from one specialist to another without a clear answer. In 2020, researchers described VEXAS syndrome as a newly recognized condition that helped connect this puzzling mix of symptoms into one diagnosis.
That discovery was an important turning point because it showed that some adults with severe, unexplained inflammation and blood-related problems were not dealing with separate illnesses after all. Instead, these problems could be part of the same underlying disorder. Early reports focused on adults who became sick later in life, often after years of symptoms, which helped explain why VEXAS syndrome had been missed in the past. Once doctors began to recognize the pattern, more people were correctly diagnosed.
The history of VEXAS syndrome is still very recent compared with many other conditions. Even so, the pace of learning has been fast. Researchers soon linked the syndrome to changes in blood-forming cells that arise during life rather than being present from birth, and this reshaped how doctors think about some inflammatory diseases in adults. As awareness has grown, VEXAS syndrome has become an important example of how modern research can uncover a condition that had likely been hiding in plain sight.
This short history also helps explain why early symptoms of VEXAS syndrome can be confusing. Many of the problems overlap with better-known rheumatologic, skin, lung, or blood disorders, so people may first receive another diagnosis. Today, doctors are more alert to VEXAS syndrome when inflammation is severe, persistent, and difficult to explain, which can lead to earlier testing and more focused care.